Platelet-rich plasma in osteoarthritis treatment: review of current evidence
[pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2019/03/PRP-in-OA-Feb-2019.pdf" title="PRP in Osteoarthritis Feb 2019"]
[pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2019/03/PRP-in-OA-Feb-2019.pdf" title="PRP in Osteoarthritis Feb 2019"]
[pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2019/01/1-PRP-1st-Choice-in-Treating-OA-of-Knee-Oct-2018.pdf" title="1 PRP 1st Choice in Treating OA of Knee Oct 2018"]
[pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/Stem-Cell-Tx-of-Osteoarthritis-March-2018.pdf" title="Stem Cell Tx of Osteoarthritis March 2018"]
Back pain is the second leading cause of disability among American adults and is currently treated either with conservative therapy or interventional pain procedures. [pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/PRP-and-Stem-Cells-in-Chronic-Low-Back-Pain-May-2017.pdf" title="PRP and Stem Cells in Chronic Low Back Pain May 2017"]
Osteoarthritis (OA) of the knee is a progressive disease involving the intra-articular (IA) tibiofemoral and patellofemoral cartilage1). Conservative treatment modalities are the first choice in younger and middle-aged populations with cartilage damage and OA of the knee. [pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Knee-OA-June-2017.pdf" title="PRP in Knee OA June 2017"]